Health officials have warned hospitals there could be a critical shortage of blood culture bottles. What does that mean for ...

Trump often invokes the Right to Try Act. Who wouldn't want to let people who are dying and desperate try something that ...

A special committee of the board of directors of 23andMe rejected an offer from the company’s CEO, Anne Wojcicki, to take the ...

The FDA has approved a cutting-edge T cell immunotherapy for a rare soft tissue cancer called synovial sarcoma, which can ...

The rhetoric being thrown at virologists must be toned down. Viruses are the real threats to humanity, not virologists.

It’s time for more answers about why women athletes — of all skill levels and in all sports — disproportionately experience ...

The FDA has approved a cutting-edge treatment relying on T cells for a rare cancer that arises in the body’s soft tissues, ...

HCA is seeking more money for its hospitals, while UnitedHealth is looking to hold down costs, in states including Texas and ...

As uses of liquid biopsy grow, and new uses inch closer to the clinical setting, the risk they may exacerbate existing health ...

Moderna cut its full-year sales guidance from $4 billion to a range of $3 billion to $3.5 billion, saying that contracting in ...

Patients and their families lose if they don't have access to lower-cost biosimilars, and taxpayers lose when Medicare and ...

Private investors are eager to back companies that run medical billing and other administrative services for hospitals and ...